Co-Authors
This is a "connection" page, showing publications co-authored by Hangping Yao and Xiangyun Lu.
Connection Strength
1.037
-
Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection. Cell Res. 2021 01; 31(1):25-36.
Score: 0.229
-
Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo. Cell Discov. 2020 Oct 29; 6(1):76.
Score: 0.228
-
Molecular Architecture of the SARS-CoV-2 Virus. Cell. 2020 10 29; 183(3):730-738.e13.
Score: 0.225
-
The low contagiousness and new A958D mutation of SARS-CoV-2 in children: An observational cohort study. Int J Infect Dis. 2021 Oct; 111:347-353.
Score: 0.060
-
Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study. Front Immunol. 2021; 12:708184.
Score: 0.060
-
Retraction Note to: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19. BMC Infect Dis. 2021 Jul 09; 21(1):672.
Score: 0.060
-
Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage. J Proteome Res. 2021 07 02; 20(7):3463-3474.
Score: 0.059
-
Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19. BMC Infect Dis. 2021 Apr 16; 21(1):357.
Score: 0.059
-
Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site. Emerg Microbes Infect. 2020 Dec; 9(1):1474-1488.
Score: 0.057